查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1800188

全球注射器市场：2025-2030 年预测

Global Syringe Market - Forecasts fom 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计注射器市场规模将从 2025 年的 104.91 亿美元成长至 2030 年的 151.48 亿美元，复合年增长率为 7.62%。

受慢性病发病率上升和人口快速老化的推动，注射器市场预计将经历显着增长。注射器需求的成长与常规医疗介入的需求密切相关，例如糖尿病患者的胰岛素注射以及其他慢性病患者的药物输送。此外，全球疫苗接种计划的增加以及人们对其重要性的认识不断提高，也进一步推动了市场扩张。儘管高昂的製造成本和复杂的供应链等挑战可能会阻碍成长，但强劲的需求仍支撑着市场，尤其是在疾病高发且医疗保健体系发达的地区，例如美国。

主要成长要素

慢性病盛行率上升

全球慢性病（尤其是糖尿病、心血管疾病和癌症）盛行率的上升是注射器市场的主要驱动力。频繁注射（例如用于糖尿病管理的胰岛素）的需求显着推动了注射器的需求。心血管疾病、癌症和慢性呼吸系统疾病等非传染性疾病（NCD）的盛行率不断上升，进一步推动了治疗和管理通讯协定中对注射器的需求。由于生活方式因素和全球医疗保健覆盖面的扩大，预计这一趋势将持续下去。

人口老化

全球老年人口的成长对市场成长做出了重大贡献，因为老年人更容易患上需要注射治疗的慢性疾病。随着全球老年人口的增加，用于药物管理和疾病管理的注射器的需求预计会增加，特别是对于糖尿病和类风湿性关节炎等需要定期注射的疾病。

增加疫苗接种计划

在全球范围内，疫苗接种在疾病预防中的作用日益受到重视，疫苗接种计画也随之扩展，从而推动了注射器的需求。这些计画得到了政府和医疗机构的支持，凸显了对安全高效注射器解决方案的需求，随着越来越多的人寻求预防感染疾病和慢性病，注射器市场的需求将进一步增长。

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 调查范围
  • 市场区隔

第三章 经营状况

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策法规
  • 策略建议

第四章 技术展望

第五章全球注射器市场（按类型）

  • 介绍
  • 胰岛素注射器
  • 一次性注射器
    • 传统注射器
      • 偏心尖注射器
      • 导管头注射器
      • 鲁尔锁注射器
    • 安全注射器
    • 预填充註射器
  • 其他的

第六章全球注射器市场（按材料）

  • 介绍
  • 玻璃
  • 塑胶
  • 防锈的

第七章 全球注射器市场（依注射器尺寸）

  • 介绍
  • 小容量注射器
  • 大容量注射器

第八章全球注射器市场（按地区）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 台湾
    • 泰国
    • 印尼
    • 其他的

第九章竞争格局及分析

  • 主要企业和策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争对手仪表板

第十章：公司简介

  • Becton, Dickinson and Company
  • B. Braun Melsungen
  • Terumo
  • Teleflex
  • Nipro
  • ICU Medical
  • Cardinal Health
  • HMD Healthcare
  • Hamilton Company
  • Advancecare Pharma USA
  • Baxter International

第十一章 附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061611594

The global syringe market is expected to grow from USD 10.491 billion in 2025 to USD 15.148 billion in 2030, at a CAGR of 7.62%.

The global syringe market is poised for significant growth, driven by the increasing prevalence of chronic diseases and a rapidly aging population. The rising demand for syringes is closely tied to the need for regular medical interventions, such as insulin administration for diabetes and drug delivery for other chronic conditions. Additionally, growing global immunization programs and heightened awareness of their importance further propel market expansion. While challenges such as high production costs and supply chain complexities may hinder growth, the market is supported by robust demand, particularly in regions with high disease prevalence and advanced healthcare systems like the United States.

Key Growth Drivers

Rising Prevalence of Chronic Diseases

The global increase in chronic diseases, particularly diabetes, cardiovascular conditions, and cancer, is a major driver of the syringe market. The need for frequent injections, such as insulin for diabetes management, significantly boosts syringe demand. The growing incidence of non-communicable diseases (NCDs), including cardiovascular illnesses, cancers, and chronic respiratory conditions, further fuels the need for syringes in treatment and management protocols. This trend is expected to continue, driven by lifestyle factors and increasing healthcare access worldwide.

Aging Population

The global rise in the geriatric population significantly contributes to market growth, as elderly individuals are more prone to chronic conditions requiring injectable treatments. With aging populations increasing worldwide, the demand for syringes for drug administration and disease management is expected to rise, particularly for conditions like diabetes and rheumatoid arthritis, which often necessitate regular injections.

Growing Immunization Programs

Increased global awareness of immunization's role in preventing diseases has led to expanded vaccination programs, driving syringe demand. These programs, supported by governments and health organizations, emphasize the need for safe and efficient syringe solutions, further bolstering market growth as populations seek protection against infectious and chronic diseases.

Market Segmentation

By Geography

The syringe market is segmented into North America, South America, Europe, the Middle East and Africa, and Asia-Pacific. The United States is a key market, driven by the high prevalence of chronic diseases like diabetes and cancer, which require frequent syringe use for treatments such as insulin injections and chemotherapy. The country's advanced healthcare infrastructure and focus on innovation further support market growth. Asia-Pacific is expected to witness rapid expansion due to increasing healthcare investments and a growing patient pool in countries like India and China.

Competitive Landscape

Key players, such as Terumo Pharmaceutical Solutions and Nephron Pharmaceuticals Corporation, are driving innovation in the syringe market. These companies focus on developing advanced syringe solutions, such as polymer and cyclic olefin copolymer (COC) syringes, tailored for high-viscosity biotech drugs and improved durability, meeting the evolving needs of the healthcare industry.

The global syringe market is set for robust growth, propelled by the rising prevalence of chronic diseases, an aging population, and expanding immunization programs. The United States leads due to its high disease burden and advanced healthcare systems, while Asia-Pacific shows strong growth potential. Despite challenges like production costs, innovations in syringe design and materials by key players ensure the market's positive trajectory, addressing critical needs in chronic disease management and vaccination efforts.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2020 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation:

By Type

  • Insulin Syringe
  • Disposable Syringes
  • Conventional Syringe
  • Eccentric Tip Syringe
  • Catheter Tip Syringe
  • Luer Lock Syringe
  • Safety Syringes
  • Prefilled Syringes
  • Others

By Material

  • Glass
  • Plastic
  • Stainless Steel

By Syringe Size

  • Smaller Volume Syringe
  • Larger Volume Syringe

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL SYRINGE MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Insulin Syringe
  • 5.3. Disposable Syringes
    • 5.3.1. Conventional Syringe
      • 5.3.1.1. Eccentric Tip Syringe
      • 5.3.1.2. Catheter Tip Syringe
      • 5.3.1.3. Luer Lock Syringe
    • 5.3.2. Safety Syringes
    • 5.3.3. Prefilled Syringes
  • 5.4. Others

6. GLOBAL SYRINGE MARKET BY MATERIAL

  • 6.1. Introduction
  • 6.2. Glass
  • 6.3. Plastic
  • 6.4. Stainless Steel

7. GLOBAL SYRINGE MARKET BY SYRINGE SIZE

  • 7.1. Introduction
  • 7.2. Smaller Volume Syringe
  • 7.3. Larger Volume Syringe

8. GLOBAL SYRINGE MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. United States
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Others
  • 8.5. Middle East & Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Taiwan
    • 8.6.6. Thailand
    • 8.6.7. Indonesia
    • 8.6.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Becton, Dickinson and Company
  • 10.2. B. Braun Melsungen
  • 10.3. Terumo
  • 10.4. Teleflex
  • 10.5. Nipro
  • 10.6. ICU Medical
  • 10.7. Cardinal Health
  • 10.8. HMD Healthcare
  • 10.9. Hamilton Company
  • 10.10. Advancecare Pharma USA
  • 10.11. Baxter International

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations